Stay updated on INTRINSIC Clinical Trial: Tailored Metastatic CRC Therapies
Sign up to get notified when there's something new on the INTRINSIC Clinical Trial: Tailored Metastatic CRC Therapies page.

Latest updates to the INTRINSIC Clinical Trial: Tailored Metastatic CRC Therapies page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe webpage has been updated to include new drug names related to metastatic colorectal cancer, such as Atezolizumab, Tiragolumab, and others, while significant details about the study's design and eligibility criteria have been removed.SummaryDifference20%
- Check20 days agoChange DetectedThe page has updated its revision number to v2.14.4 and changed its status to 'Active, not recruiting'. Additionally, the date has been updated to 2025-04-06.SummaryDifference0.7%
- Check27 days agoChange DetectedThe page has been updated to reflect a new last update date of March 25, 2025, and a revision change to version 2.14.3, replacing the previous date of March 10, 2025, and version 2.14.2.SummaryDifference0.1%
- Check49 days agoChange DetectedThe study has increased its locations from 72 to 73 and has changed its status from 'Active, not recruiting' to 'Completed'.SummaryDifference0.8%
- Check63 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.9%
- Check78 days agoChange DetectedThe page has updated its recruitment status to 'Recruiting' and removed previous dates, indicating a shift in availability for participation. Additionally, there is a notice about heavy traffic affecting service performance.SummaryDifference2%
Stay in the know with updates to INTRINSIC Clinical Trial: Tailored Metastatic CRC Therapies
Enter your email address, and we'll notify you when there's something new on the INTRINSIC Clinical Trial: Tailored Metastatic CRC Therapies page.